Asa and Zelboraf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Asa (aspirin) and Zelboraf (vemurafenib). Common drug interactions include alanine aminotransferase increased among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Asa and Zelboraf. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Asa?

Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,557 Asa users. Check the latest studies of Asa.

What is Zelboraf?

Zelboraf has active ingredients of vemurafenib. eHealthMe is studying from 8,392 Zelboraf users. Check the latest studies of Zelboraf.

On Jul, 16, 2026

13 people who take Asa and Zelboraf together, and have interactions are studied.

What are the common drug interactions of Asa and Zelboraf, by gender? *:

female:

Alanine aminotransferase increased
Arthralgia (joint pain)
Aspartate aminotransferase increased
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Electrocardiogram qt prolonged
Fatigue (feeling of tiredness)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)

male:

Arthralgia (joint pain)
Rash
Pain
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Weight decreased
Weight increased
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Sunburn
Mass

What are the common drug interactions of Asa and Zelboraf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Haemoglobin decreased
Rash

50-59:

n/a

60+:

Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Weight decreased
Weight increased
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Asthenia (weakness)
Blood pressure diastolic decreased
Body temperature decreased

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 9 people, 69.23%
High Blood Pressure: 5 people, 38.46%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 15.38%
Thyroid Diseases: 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Pain: 1 person, 7.69%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 7.69%
Lymphoma (cancer that begins in immune system cells): 1 person, 7.69%
Hairy Cell Leukaemia (a type of blood cancer): 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Asa and Zelboraf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously